AU

Biosceptre International Limited


USPTO Granted Patents = 12



Forward Citations = 213

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Julian Alexander Barden (11 out of 32 patents)

silverMedal Angus Gidley-Baird (11 out of 25 patents)

bronzeMedal Glenn Ronald Pilkington (2 out of 8 patents)

4 Philip Jones (1 out of 13 patents)

5 Neil Brewis (1 out of 5 patents)

6 Steven Grant (1 out of 20 patents)

7 Julia Alexander Barden (1 out of 1 patent)

8 Augus Gidley-Baird (0 patent)

9 Michael Slater (0 patent)


12 patents:

Biosceptre is a clinical-stage biotech company focused on developing targeted therapies for cancer. They specialize in a unique class of immunotherapies known as CBAS antibodies that have demonstrated high efficacy in preclinical studies. With multiple programs in development, Biosceptre aims to transform the treatment landscape for a variety of cancer types by targeting novel cancer markers with their innovative antibody platform.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

12 Patents

#15 in

#316 in Australia

#46,762 in the World

...
AU
Forward Citations = 213

7 inventors:

Please report any incorrect information to support@idiyas.com
Loading…